nodes	percent_of_prediction	percent_of_DWPC	metapath
Testolactone—Alopecia—Topotecan—peripheral nervous system neoplasm	0.0133	0.014	CcSEcCtD
Testolactone—Drospirenone—BCHE—peripheral nervous system neoplasm	0.0133	0.265	CrCbGaD
Testolactone—Alopecia—Tretinoin—peripheral nervous system neoplasm	0.0132	0.0139	CcSEcCtD
Testolactone—Alopecia—Isotretinoin—peripheral nervous system neoplasm	0.0132	0.0139	CcSEcCtD
Testolactone—Alopecia—Melphalan—peripheral nervous system neoplasm	0.013	0.0137	CcSEcCtD
Testolactone—Erythema—Tretinoin—peripheral nervous system neoplasm	0.013	0.0137	CcSEcCtD
Testolactone—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.013	0.0137	CcSEcCtD
Testolactone—Ill-defined disorder—Topotecan—peripheral nervous system neoplasm	0.0121	0.0128	CcSEcCtD
Testolactone—Ill-defined disorder—Tretinoin—peripheral nervous system neoplasm	0.012	0.0127	CcSEcCtD
Testolactone—Ill-defined disorder—Isotretinoin—peripheral nervous system neoplasm	0.012	0.0127	CcSEcCtD
Testolactone—Malaise—Topotecan—peripheral nervous system neoplasm	0.0118	0.0124	CcSEcCtD
Testolactone—Malaise—Tretinoin—peripheral nervous system neoplasm	0.0117	0.0123	CcSEcCtD
Testolactone—Malaise—Isotretinoin—peripheral nervous system neoplasm	0.0117	0.0123	CcSEcCtD
Testolactone—Discomfort—Topotecan—peripheral nervous system neoplasm	0.011	0.0116	CcSEcCtD
Testolactone—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.0109	0.0115	CcSEcCtD
Testolactone—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.0109	0.0115	CcSEcCtD
Testolactone—Alopecia—Dactinomycin—peripheral nervous system neoplasm	0.0108	0.0113	CcSEcCtD
Testolactone—Glossitis—Epirubicin—peripheral nervous system neoplasm	0.0107	0.0112	CcSEcCtD
Testolactone—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.0106	0.0112	CcSEcCtD
Testolactone—Oedema—Tretinoin—peripheral nervous system neoplasm	0.0106	0.0112	CcSEcCtD
Testolactone—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.0106	0.0112	CcSEcCtD
Testolactone—Oedema—Melphalan—peripheral nervous system neoplasm	0.0105	0.011	CcSEcCtD
Testolactone—Anorexia—Topotecan—peripheral nervous system neoplasm	0.0102	0.0107	CcSEcCtD
Testolactone—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.0101	0.0106	CcSEcCtD
Testolactone—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.0101	0.0106	CcSEcCtD
Testolactone—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.00999	0.0105	CcSEcCtD
Testolactone—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00997	0.0105	CcSEcCtD
Testolactone—Glossitis—Doxorubicin—peripheral nervous system neoplasm	0.00989	0.0104	CcSEcCtD
Testolactone—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.00985	0.0104	CcSEcCtD
Testolactone—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00984	0.0104	CcSEcCtD
Testolactone—Triamcinolone—BCHE—peripheral nervous system neoplasm	0.00981	0.196	CrCbGaD
Testolactone—Alopecia—Vincristine—peripheral nervous system neoplasm	0.00962	0.0101	CcSEcCtD
Testolactone—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00959	0.0101	CcSEcCtD
Testolactone—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.00957	0.0101	CcSEcCtD
Testolactone—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00951	0.01	CcSEcCtD
Testolactone—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00951	0.01	CcSEcCtD
Testolactone—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00939	0.00989	CcSEcCtD
Testolactone—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00929	0.00977	CcSEcCtD
Testolactone—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00921	0.0097	CcSEcCtD
Testolactone—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00921	0.0097	CcSEcCtD
Testolactone—Pain—Topotecan—peripheral nervous system neoplasm	0.00913	0.00962	CcSEcCtD
Testolactone—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.00913	0.00961	CcSEcCtD
Testolactone—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00909	0.00957	CcSEcCtD
Testolactone—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00906	0.00954	CcSEcCtD
Testolactone—Pain—Tretinoin—peripheral nervous system neoplasm	0.00906	0.00954	CcSEcCtD
Testolactone—Pain—Melphalan—peripheral nervous system neoplasm	0.00894	0.00941	CcSEcCtD
Testolactone—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00893	0.0094	CcSEcCtD
Testolactone—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00887	0.00934	CcSEcCtD
Testolactone—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.0088	0.00927	CcSEcCtD
Testolactone—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00873	0.00919	CcSEcCtD
Testolactone—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00873	0.00919	CcSEcCtD
Testolactone—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00866	0.00912	CcSEcCtD
Testolactone—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.00851	0.00896	CcSEcCtD
Testolactone—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00838	0.00883	CcSEcCtD
Testolactone—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00828	0.00871	CcSEcCtD
Testolactone—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00826	0.00869	CcSEcCtD
Testolactone—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00803	0.00845	CcSEcCtD
Testolactone—Alopecia—Etoposide—peripheral nervous system neoplasm	0.0078	0.00821	CcSEcCtD
Testolactone—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00778	0.00819	CcSEcCtD
Testolactone—Oedema—Vincristine—peripheral nervous system neoplasm	0.00774	0.00815	CcSEcCtD
Testolactone—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00765	0.00806	CcSEcCtD
Testolactone—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00756	0.00796	CcSEcCtD
Testolactone—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00753	0.00793	CcSEcCtD
Testolactone—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00741	0.0078	CcSEcCtD
Testolactone—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00738	0.00776	CcSEcCtD
Testolactone—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00721	0.00759	CcSEcCtD
Testolactone—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00714	0.00751	CcSEcCtD
Testolactone—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00713	0.0075	CcSEcCtD
Testolactone—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00705	0.00742	CcSEcCtD
Testolactone—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00698	0.00735	CcSEcCtD
Testolactone—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00695	0.00731	CcSEcCtD
Testolactone—Malaise—Etoposide—peripheral nervous system neoplasm	0.00693	0.00729	CcSEcCtD
Testolactone—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00687	0.00723	CcSEcCtD
Testolactone—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00684	0.0072	CcSEcCtD
Testolactone—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00679	0.00715	CcSEcCtD
Testolactone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00674	0.00709	CcSEcCtD
Testolactone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00674	0.00709	CcSEcCtD
Testolactone—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00673	0.00708	CcSEcCtD
Testolactone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00665	0.007	CcSEcCtD
Testolactone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00662	0.00697	CcSEcCtD
Testolactone—Pain—Vincristine—peripheral nervous system neoplasm	0.00662	0.00697	CcSEcCtD
Testolactone—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00652	0.00687	CcSEcCtD
Testolactone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00646	0.0068	CcSEcCtD
Testolactone—Nausea—Topotecan—peripheral nervous system neoplasm	0.00634	0.00668	CcSEcCtD
Testolactone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00629	0.00663	CcSEcCtD
Testolactone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00629	0.00663	CcSEcCtD
Testolactone—Nausea—Melphalan—peripheral nervous system neoplasm	0.00621	0.00654	CcSEcCtD
Testolactone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00614	0.00647	CcSEcCtD
Testolactone—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00598	0.00629	CcSEcCtD
Testolactone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00595	0.00626	CcSEcCtD
Testolactone—Pain—Cisplatin—peripheral nervous system neoplasm	0.00585	0.00616	CcSEcCtD
Testolactone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00564	0.00594	CcSEcCtD
Testolactone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00563	0.00592	CcSEcCtD
Testolactone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00551	0.0058	CcSEcCtD
Testolactone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00545	0.00574	CcSEcCtD
Testolactone—Pain—Etoposide—peripheral nervous system neoplasm	0.00536	0.00564	CcSEcCtD
Testolactone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00517	0.00544	CcSEcCtD
Testolactone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00514	0.00542	CcSEcCtD
Testolactone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00511	0.00537	CcSEcCtD
Testolactone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00492	0.00518	CcSEcCtD
Testolactone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00477	0.00502	CcSEcCtD
Testolactone—Nausea—Vincristine—peripheral nervous system neoplasm	0.0046	0.00484	CcSEcCtD
Testolactone—Methylprednisolone—ABCB1—peripheral nervous system neoplasm	0.00456	0.0911	CrCbGaD
Testolactone—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00437	0.0046	CcSEcCtD
Testolactone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00435	0.00458	CcSEcCtD
Testolactone—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00431	0.00453	CcSEcCtD
Testolactone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00406	0.00428	CcSEcCtD
Testolactone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.00404	0.00426	CcSEcCtD
Testolactone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00399	0.0042	CcSEcCtD
Testolactone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00399	0.0042	CcSEcCtD
Testolactone—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00398	0.00419	CcSEcCtD
Testolactone—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00388	0.00409	CcSEcCtD
Testolactone—Nausea—Etoposide—peripheral nervous system neoplasm	0.00372	0.00392	CcSEcCtD
Testolactone—Spironolactone—ABCB1—peripheral nervous system neoplasm	0.0037	0.074	CrCbGaD
Testolactone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.0037	0.00389	CcSEcCtD
Testolactone—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00362	0.00381	CcSEcCtD
Testolactone—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00359	0.00378	CcSEcCtD
Testolactone—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00351	0.0037	CcSEcCtD
Testolactone—Prednisone—ABCB1—peripheral nervous system neoplasm	0.00348	0.0697	CrCbGaD
Testolactone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00335	0.00353	CcSEcCtD
Testolactone—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00335	0.00353	CcSEcCtD
Testolactone—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00325	0.00342	CcSEcCtD
Testolactone—Prednisolone—ABCB1—peripheral nervous system neoplasm	0.00321	0.0643	CrCbGaD
Testolactone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00316	0.00332	CcSEcCtD
Testolactone—Betamethasone—ABCB1—peripheral nervous system neoplasm	0.00315	0.0629	CrCbGaD
Testolactone—Estrone—ABCB1—peripheral nervous system neoplasm	0.00311	0.0622	CrCbGaD
Testolactone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.0031	0.00326	CcSEcCtD
Testolactone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00305	0.00322	CcSEcCtD
Testolactone—Pain—Epirubicin—peripheral nervous system neoplasm	0.003	0.00316	CcSEcCtD
Testolactone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00292	0.00307	CcSEcCtD
Testolactone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.0029	0.00305	CcSEcCtD
Testolactone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00283	0.00298	CcSEcCtD
Testolactone—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00278	0.00293	CcSEcCtD
Testolactone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00268	0.00282	CcSEcCtD
Testolactone—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00223	0.00235	CcSEcCtD
Testolactone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00209	0.0022	CcSEcCtD
Testolactone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00207	0.00218	CcSEcCtD
Testolactone—Progesterone—ABCB1—peripheral nervous system neoplasm	0.002	0.04	CrCbGaD
Testolactone—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00193	0.00203	CcSEcCtD
Testolactone—Testosterone—ABCB1—peripheral nervous system neoplasm	0.00189	0.0378	CrCbGaD
Testolactone—Dexamethasone—ABCB1—peripheral nervous system neoplasm	0.00183	0.0366	CrCbGaD
